Soleno Therapeutics News

Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Soleno Therapeutics (SLNO)

TipRanksMay 23 06:00

Oppenheimer: The Soleno Therapeutics (SLNO.US) rating was maintained, and the target price was adjusted from better than the market to the better than the market rating, and the target price was adjusted from $65.00 to $59.00.

Zhitong FinanceMay 13 07:40

Soleno Therapeutics Analyst Ratings

BenzingaMay 13 07:35

Oppenheimer Maintains Outperform on Soleno Therapeutics, Lowers Price Target to $59

BenzingaMay 13 07:36

Soleno Therapeutics (SLNO) Receives a Buy From Stifel Nicolaus

TipRanksMay 12 21:06

Soleno Therapeutics (SLNO.US) was first covered by Baird, which gave it an superior market rating, with a target price of $72.00.

Zhitong FinanceMay 10 04:21

Soleno Therapeutics Analyst Ratings

BenzingaMay 10 04:17

Baird Initiates Coverage On Soleno Therapeutics With Outperform Rating, Announces Price Target of $72

BenzingaMay 10 04:19

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Biomea Fusion (BMEA) and Soleno Therapeutics (SLNO)

TipRanksMar 22 06:20

Analysts' Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)

TipRanksMar 18 06:00

Piper Sandler Starts Soleno Therapeutics With Overweight Rating, $93 Price Target

MT NewswiresFeb 5 09:07

Soleno Therapeutics Analyst Ratings

BenzingaFeb 5 05:13

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO), Merck & Company (MRK) and Tenet Healthcare (THC)

TipRanksFeb 5 03:10

Stifel Initiates Coverage On Soleno Therapeutics With Buy Rating, Announces Price Target of $63

BenzingaJan 23 03:39

Soleno Therapeutics Analyst Ratings

BenzingaJan 23 03:38

Oppenheimer Maintains Outperform on Soleno Therapeutics, Raises Price Target to $47

BenzingaJan 2 10:49

Soleno Therapeutics Analyst Ratings

BenzingaJan 2 10:46

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO), Agilon Health (AGL) and Integer Holdings (ITGR)

TipRanksJan 2 06:40

Soleno Therapeutics Analyst Ratings

BenzingaNov 21, 2023 07:41

Oppenheimer Adjusts Soleno Therapeutics Price Target to $44 From $39, Maintains Outperform Rating

MT NewswiresNov 9, 2023 07:59